#United States #Richmond #Slope #CellCarta #Lab Management

Slope and CellCarta Strengthen Their Collaboration

In a significant development for the clinical research field, Slope and CellCarta have taken their collaboration to the next level by formalizing their Kit Inventory Portal (KIP) partnership. This strategic move follows a highly successful pilot program that established Slope as a crucial component of CellCarta's logistics strategy, catering to both new and existing clients. The partnership aims to optimize sample collection kit ordering, manage inventory efficiently, and streamline resupply workflows, ultimately offering a solution that is user-friendly for clinical sites and significantly reduces kit waste by up to 71%.

Clinical research is evolving, and the partnership between Slope and CellCarta highlights the impact of innovative solutions in enhancing the drug development process. Slope's platform simplifies the ordering process for clinical sites, enabling automatic resupply capabilities and customizable approval workflows. Orders made through Slope are seamlessly transmitted to CellCarta's ERP system, while shipment tracking updates are synced automatically to site workspaces. This real-time update feature allows clinical sites to manage inventory levels effectively, thereby reducing the complexities involved in on-hand inventory management.

The Need for Modern Biospecimen Logistics

The growing demands of the biopharmaceutical industry necessitate efficient logistics solutions. Ben Carmel, Chief Revenue Officer at Slope, emphasized that the evolution from a pilot program to a formalized partnership reaffirms the operational benefits that Slope's platform offers to Contract Research Organizations (CROs), clinical trial sites, and sponsors alike. He noted, "Organizations in the CRO sector recognize that modern biospecimen logistics infrastructure is not just advantageous, but essential for staying competitive in the market and meeting the expectations of clients."

Echoing this sentiment, Kristien Verhoeven, Senior Vice-President of Histopathology, Genomics, and Logistics at CellCarta, stated that adopting the Kit Inventory Portal as a standard across their portfolio illustrates how the right technology can transform clinical logistics from a challenging issue into a competitive edge. This partnership alleviates burdens on clinical sites while providing essential visibility to stakeholders and minimizing the costly waste associated with laboratory kits.

Enhancing Clinical Research Through Technology

The collaboration between Slope and CellCarta serves as a prime example of how pilot programs can transition into durable strategic partnerships when technology delivers measurable improvements. By minimizing manual interventions, boosting inventory visibility, and enhancing the overall research site experience, stakeholders can pivot their focus from operational intricacies to advancing clinical science.

The Slope-CellCarta partnership is poised to revolutionize clinical logistics, allowing researchers and organizations to concentrate their resources on critical scientific endeavors rather than being bogged down by operational hurdles. This shift paves the way for more efficient clinical trials and accelerates the timeline for bringing innovative treatments to market.

About CellCarta

CellCarta stands as a leading global CRO, serving the biopharmaceutical sector with a strong reputation for quality and reliability. The company holds CAP accreditations and CLIA certifications for advanced assays, ensuring compliance with high standards across multiple regions, including Canada, the United States, Belgium, Australia, and China. The comprehensive biomarker testing services and solutions offered by CellCarta are tailored to meet the needs of the world's foremost pharmaceutical companies, guided by integrated platforms that cover immunology, histopathology, proteomics, and genomics. As a full-cycle partner in drug discovery, CellCarta offers unmatched support throughout the entire process from early-stage research to late-stage clinical trials.

About Slope

Slope has established itself as the premier vendor-agnostic platform, providing end-to-end management of biospecimens and clinical inventory. With a trusted presence in over 23 countries and assistance to more than 2,200 sites, Slope boasts impressive metrics, including a 71% reduction in laboratory kit waste and 98% site adoption rates for sponsor-contracted trials. The platform integrates all aspects of the biospecimen lifecycle, optimizing logistics from supply chains to data exchange with core clinical systems. With Slope, clinical trials become more efficient, cost-effective, and streamlined, ultimately enhancing outcomes across the research spectrum.

Together, Slope and CellCarta are setting new standards for logistics in clinical trials, showcasing how technology-driven solutions can solve longstanding issues in biopharmaceutical research.